Evidence map›Paper›PMID 33007381›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2020

Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19.

M E O'Callaghan, A Jay, G Kichenadasse, K L Moretti

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M E O'CallaghanUrology Unit, Flinders Medical Centre, Bedford Park, Australia; College of Medicine and Public Health, Flinders University, Bedford Park, Australia; The Freemasons Centre for Male Health and Wellbeing, Adelaide University, Adelaide. Electronic address: michael.ocallaghan@health.sa.gov.au.
A JayUrology Unit, Flinders Medical Centre, Bedford Park, Australia; College of Medicine and Public Health, Flinders University, Bedford Park, Australia.
G KichenadasseCollege of Medicine and Public Health, Flinders University, Bedford Park, Australia; Medical Oncology Unit, Flinders Medical Centre, Bedford Park, Australia.
K L MorettiCollege of Medicine and Public Health, Flinders University, Bedford Park, Australia; The Freemasons Centre for Male Health and Wellbeing, Adelaide University, Adelaide; Urology Unit, The Queen Elizabeth Hospital, Woodville, Australia; The UniSA Allied Health & Human Performance, The University of South Australia, Adelaide; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Flinders University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Androgen AntagonistsCOVID-19Prostatic NeoplasmsHumansMalePandemicsAndrogen Antagonists

Identifiers

PMID33007381
PMCPMC7525325
OpenAlexW3091165260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.